Medium materiality6/10
ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
ANIP price target lowered to $119 by Guggenheim; posted price $78.25.
- ANIP target lowered to $119; price $78.25.
Key facts
- 01
Target: $119
- 02
Posted price: $78.25
- 03
Analyst firm: Guggenheim
- 04
Analyst: Vamil Divan
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.